Clinical trials: Sphenopalatine Ganglion Block
- Condition Sphenopalatine Ganglion Block
- Funder type Industry (pharma, biotech, devices)
- Has posted results yes
Chronic Migraine
Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine
Migraine imposes a substantial burden on patients in terms of diminished daily functioning, quality of life, and financial loss.
- Trial name
- Tx360 (NCT01709708)
- Testing
- Marcaine, Saline
- Where
- 2 sites in United States
- Volunteers
- 41 people
- Sponsor
- Tian Medical Inc.